We are delighted to invite you to our virtual Global Indirect Tax Health Industry Convention “Succeeding through uncertainty” on Thursday 6 May 2021 from 2pm to 6pm CEST. We will discuss the latest hot topics in the pharma, healthcare and life science industry from an indirect tax perspective and beyond.
The incredible pace of change in indirect taxes in the pharma, healthcare and life sciences industry shows no sign of slowing down. Digital transformation, changes in supply chains due to the pandemic, Brexit and complex developments in EU legislation are just some of the factors that are currently having a major impact on this industry and affecting almost every aspect of our business lives.
As the COVID-19 situation develops, tax and regulatory specialists within the pharmaceutical & life sciences industry are increasingly facing complex challenges. Efficient and pragmatic solutions have to be realised, with fewer resources, in line with the changing local legislation.
The exchange of information is the best practice in this industry to support and inspire you in your daily business.
I would like to invite you to our next
webinar “PwC webinar – “Sourcing and manufacturing without side
effects!” which will be held on 31 March 2020 from 3:00 pm to 4:00 pm and
on 1 April 2020 from 9.00 am to 10.00 am.
We will also include some ITX Updates
related on COVID-19.
I am pleased to invite you to our Webinar on Precision Medicine and Accurate Indirect Tax
During this digital presentation our panel of experts will give you an overview of possible indirect tax implications within the pharma sector. This panel consists of many tax specialists of the pharmaceutical sector and PwC’s international indirect tax experts. Experts, who are dedicated to the pharmaceutical industry.
I will use my time slot to discuss the implications for Switzerland including which countries will be covered.
You will have the opportunity to exchange your experiences and views on the issue with other international leaders.
In December the United States enacted the most comprehensive tax reform in more than 30 years. For the Pharmaceutical and Life Sciences sector, the changes won’t just impact US based businesses but companies based outside the US who trade there.
Join PwC’s tax and industry specialists in a live webinar from New York.
Our specialists will be available to take questions following the presentation.
15 May 2018 | 14:00 BST (London) / 15:00 CEST (Paris) / 9:00AM EST (New York)
Presenter: Kathy Michael, PwC’s US Pharmaceutical & Life Sciences Tax Sector Leader
Access instructions: Click here to register and access the webinar. If you cannot view the webinar on your PC, you may dial in to the audio-only phone line: +1 651 291 3245 / Passcode: 448492 #
If you have any questions please don’t hesitate to contact me.